Sanofi (SNY) Change in Intangibles (2018 - 2022)

Sanofi (SNY) posted Change in Intangibles of $103.0 million for Q4 2022, down 86.15% sequentially from $743.8 million in Q4 2019.

Sanofi (SNY) Change in Intangibles (2018 - 2022) Analysis & Trends

Sanofi has reported Change in Intangibles for 3 years, with the latest figure at $103.0 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	-
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	-
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	-
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	-
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	-
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	-
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	-
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	-
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	393.11 Mn
10	Sanofi	55.07 Bn	47.69 Bn	10.79 Bn	-

Download Data